Insilico Medicine vs Z.ai (Zhipu AI)
Relationship
Science42: DORA and AMiner do comparable work on summarization; both also serve buyers who need to draft and edit written content; larger scale (public).
Assembled from the recorded fields for this pair, not hand-checked. The comparison below is read from each company’s own profile.
5 of 8 capabilities — Shares agent orchestration, data analysis, knowledge retrieval and 2 more.
Ludbee capability tags · from the product recordsShared product type — Both ship application.
Ludbee product recordsLarger scale — Z.ai (Zhipu AI): $58.6B market cap, against Insilico Medicine's $4.3B market cap.
Ludbee scale figures · valuation, market cap or revenue estimateAligned comparison
Capability overlap
Shared · 5
Not verified for Z.ai (Zhipu AI) · 3
Recorded for Insilico Medicine. Z.ai (Zhipu AI)’s product records say nothing either way — a missing record is not a missing capability.
Not verified for Insilico Medicine · 8
Recorded for Z.ai (Zhipu AI). Insilico Medicine’s product records say nothing either way — a missing record is not a missing capability.
Products, side by side
Algorithmic pairing — assembled from recorded fields, not hand-checked
Insilico Medicine
Application
AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.
Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.
Z.ai (Zhipu AI)
Application
AI research assistant built on Zhipu's GLM models that performs academic and scholar search, AI-assisted paper reading, literature-review generation with citations, and scholarly question answering.
Deep-research assistant that searches and scrapes source websites to produce structured research reports and can emit the result as a slide deck or web page, with browser automation and video summarisation.
Zhipu's Chinese-market consumer AI assistant and agent built on the GLM model family, covering dialogue, writing, coding, translation and multimodal input.
No counterpart
Insilico Medicine sells these in a stack layer with no product recorded for Z.ai (Zhipu AI) yet — nothing on the other side to compare them against.
Platform
AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.
Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.
Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.
AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base.
End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.
Hardware
On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.
Z.ai (Zhipu AI) sells these in a stack layer with no product recorded for Insilico Medicine yet — nothing on the other side to compare them against.
AI agent
Locally installed AI agent application with 50+ preconfigured skills that performs document generation, data analysis, browser automation and messaging-app collaboration, running on Windows, macOS, iOS and Android and defaulting to the GLM-5.3 model.
Developer tool
Flat-rate monthly subscription providing GLM model access inside third-party coding agents and IDEs such as Claude Code, Codex, Cline, OpenCode, Cursor and Windsurf, billed separately from Z.ai's per-token API.